Skip to main content
Top

28-09-2024 | Original Paper

Comparison of four approaches in eliciting health state utilities with SF-6Dv2

Authors: Hosein Ameri, Thomas G. Poder

Published in: The European Journal of Health Economics

Login to get access

Abstract

Objective

To empirically compare four preference elicitation approaches, the discrete choice experiment with time (DCETTO), the Best-Worst Scaling with time (BWSTTO), DCETTO with BWSTTO (DCEBWS), and the Standard Gamble (SG) method, in valuing health states using the SF-6Dv2.

Methods

A representative sample of the general population in Quebec, Canada, completed 6 SG tasks or 13 DCEBWS (i.e., 10 DCETTO followed by 3 BWSTTO). Choice tasks were designed with the SF-6Dv2. Several models were used to estimate SG data, and the conditional logit model was used for the DCE or BWS data. The performance of SG models was assessed using prediction accuracy (mean absolute error [MAE]), goodness of fit using Bayesian information criterion (BIC), t-test, Jarque-Bera (JB) test,  Ljung-Box (LB) test, the logical consistency of the parameters, and significance levels. Comparison between approaches was conducted using acceptability (self-reported difficulty and quality levels in answering, and completion time), consistency (monotonicity of model coefficients), accuracy (standard errors), dimensions coefficient magnitude, correlation between the value sets estimated, and the range of estimated values. The variance scale factor was computed to assess individuals’ consistency in their choices for DCE and BWS approaches.

Results

Out of 828 people who completed SG and 1208 for DCEBWS tasks, a total of 724 participants for SG and 1153 for DCE tasks were included for analysis. Although no significant difference was observed in self-reported difficulties and qualities in answers among approaches, the SG had the longest completion time and excluded participants in SG were more prone to report difficulties in answering. The range of standard errors of the SG was the narrowest (0.012 to 0.015), followed by BWSTTO (0.023 to 0.035), DCEBWS (0.028 to 0.050), and DCETTO (0.028 to 0.052). The highest number of insignificant and illogical parameters was for BWSTTO. Pain dimension was the most important across dimensions in all approaches. The correlation between SG and DCEBWS utility values was the strongest (0.928), followed by the SG and BWSTTO values (0.889), and the SG and DCETTO (0.849). The range of utility values generated by SG tended to be shorter (-0.143 to 1) than those generated by the other three methods, whereas BWSTTO (-0.505 to 1) range values were shorter than DCETTO (-1.063 to 1) and DCEBWS (-0.637 to 1). The variance scale factor suggests that respondents had almost similar level of certainty or confidence in both DCE and BWS responses.

Conclusion

The SG had the narrowest value set, the lowest completion rates, the longest completion time, the best prediction accuracy, and produced an unexpected sign for one level. The BWSTTO had a narrower value set, lower completion time, higher parameter inconsistency, and higher insignificant levels compared to DCETTO and DCEBWS. The results of DCEBWS were more similar to SG in number of insignificant and illogical parameters, and correlation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brazier, J., Ratcliffe, J., Saloman, J., Tsuchiya, A.: Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press (2017) Brazier, J., Ratcliffe, J., Saloman, J., Tsuchiya, A.: Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press (2017)
2.
go back to reference Weinstein, M.C., Torrance, G., McGuire, A.: QALYs: the basics. Value in health. (2009) Weinstein, M.C., Torrance, G., McGuire, A.: QALYs: the basics. Value in health. (2009)
3.
4.
go back to reference Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health. Econ. 21(2), 271–292 (2002)CrossRefPubMed Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health. Econ. 21(2), 271–292 (2002)CrossRefPubMed
5.
go back to reference Louviere, J., Timmermans, H.: Stated preference and choice models applied to recreation research: A review. Leisure Sci. 12(1), 9–32 (1990)CrossRef Louviere, J., Timmermans, H.: Stated preference and choice models applied to recreation research: A review. Leisure Sci. 12(1), 9–32 (1990)CrossRef
6.
go back to reference Brazier, J.E., Mulhern, B.J., Bjorner, J.B., Gandek, B., Rowen, D., Alonso, J., Vilagut, G., Ware, J.E., Group, S.-D.I.P.: Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med. Care. 58(6), 557–565 (2020)CrossRefPubMed Brazier, J.E., Mulhern, B.J., Bjorner, J.B., Gandek, B., Rowen, D., Alonso, J., Vilagut, G., Ware, J.E., Group, S.-D.I.P.: Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med. Care. 58(6), 557–565 (2020)CrossRefPubMed
8.
go back to reference Mongin, P.: Expected utility theory. (1998) Mongin, P.: Expected utility theory. (1998)
9.
go back to reference Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health care Programmes. Oxford University Press (2015) Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health care Programmes. Oxford University Press (2015)
10.
go back to reference Bleichrodt, H.: A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 11(5), 447–456 (2002)CrossRefPubMed Bleichrodt, H.: A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 11(5), 447–456 (2002)CrossRefPubMed
11.
go back to reference Abellán Perpiñán, J.M., Sánchez Martínez, F.I., Martínez Pérez, J.E., Méndez, I.: Lowering the ‘floor’of the SF-6D scoring algorithm using a lottery equivalent method. Health Econ. 21(11), 1271–1285 (2012)CrossRefPubMed Abellán Perpiñán, J.M., Sánchez Martínez, F.I., Martínez Pérez, J.E., Méndez, I.: Lowering the ‘floor’of the SF-6D scoring algorithm using a lottery equivalent method. Health Econ. 21(11), 1271–1285 (2012)CrossRefPubMed
12.
go back to reference Lancsar, E., Louviere, J.: Conducting discrete choice experiments to inform healthcare decision making: A user’s guide. Pharmacoeconomics. 26, 661–677 (2008)CrossRefPubMed Lancsar, E., Louviere, J.: Conducting discrete choice experiments to inform healthcare decision making: A user’s guide. Pharmacoeconomics. 26, 661–677 (2008)CrossRefPubMed
13.
go back to reference Bansback, N., Brazier, J., Tsuchiya, A., Anis, A.: Using a discrete choice experiment to estimate health state utility values. J. Health. Econ. 31(1), 306–318 (2012)CrossRefPubMed Bansback, N., Brazier, J., Tsuchiya, A., Anis, A.: Using a discrete choice experiment to estimate health state utility values. J. Health. Econ. 31(1), 306–318 (2012)CrossRefPubMed
14.
go back to reference Stolk, E.A., Oppe, M., Scalone, L., Krabbe, P.F.: Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value Health. 13(8), 1005–1013 (2010)CrossRefPubMed Stolk, E.A., Oppe, M., Scalone, L., Krabbe, P.F.: Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value Health. 13(8), 1005–1013 (2010)CrossRefPubMed
15.
go back to reference de Bekker-Grob, E.W., Ryan, M., Gerard, K.: Discrete choice experiments in health economics: A review of the literature. Health Econ. 21(2), 145–172 (2012)CrossRefPubMed de Bekker-Grob, E.W., Ryan, M., Gerard, K.: Discrete choice experiments in health economics: A review of the literature. Health Econ. 21(2), 145–172 (2012)CrossRefPubMed
16.
go back to reference Lancaster, K.J.: A new approach to consumer theory. J. Polit. Econ. 74(2), 132–157 (1966)CrossRef Lancaster, K.J.: A new approach to consumer theory. J. Polit. Econ. 74(2), 132–157 (1966)CrossRef
17.
go back to reference Wang, H., Rowen, D.L., Brazier, J.E., Jiang, L.: Discrete choice experiments in Health State Valuation: A systematic review of Progress and New trends. Appl. Health. Econ. Health. Policy. 21(3), 405–418 (2023)CrossRefPubMedPubMedCentral Wang, H., Rowen, D.L., Brazier, J.E., Jiang, L.: Discrete choice experiments in Health State Valuation: A systematic review of Progress and New trends. Appl. Health. Econ. Health. Policy. 21(3), 405–418 (2023)CrossRefPubMedPubMedCentral
18.
go back to reference McIntosh, E., Louviere, J. (eds.): Separating Weight and Scale Value: An Exploration of best-attribute Scaling in Health Economics. Health Economists’ Study Group meeting (2002) McIntosh, E., Louviere, J. (eds.): Separating Weight and Scale Value: An Exploration of best-attribute Scaling in Health Economics. Health Economists’ Study Group meeting (2002)
19.
go back to reference Flynn, T.N., Louviere, J.J., Peters, T.J., Coast, J.: Best–worst scaling: What it can do for health care research and how to do it. J. Health. Econ. 26(1), 171–189 (2007)CrossRefPubMed Flynn, T.N., Louviere, J.J., Peters, T.J., Coast, J.: Best–worst scaling: What it can do for health care research and how to do it. J. Health. Econ. 26(1), 171–189 (2007)CrossRefPubMed
20.
go back to reference Clark, M.D., Determann, D., Petrou, S., Moro, D., de Bekker-Grob, E.W.: Discrete choice experiments in health economics: A review of the literature. Pharmacoeconomics. 32, 883–902 (2014)CrossRefPubMed Clark, M.D., Determann, D., Petrou, S., Moro, D., de Bekker-Grob, E.W.: Discrete choice experiments in health economics: A review of the literature. Pharmacoeconomics. 32, 883–902 (2014)CrossRefPubMed
21.
go back to reference Norman, R., Cronin, P., Viney, R.: A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl. Health. Econ. Health. Policy. 11, 287–298 (2013)CrossRefPubMed Norman, R., Cronin, P., Viney, R.: A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl. Health. Econ. Health. Policy. 11, 287–298 (2013)CrossRefPubMed
22.
go back to reference Viney, R., Norman, R., Brazier, J., Cronin, P., King, M.T., Ratcliffe, J., Street, D.: An Australian discrete choice experiment to value EQ-5D health states. Health Econ. 23(6), 729–742 (2014)CrossRefPubMed Viney, R., Norman, R., Brazier, J., Cronin, P., King, M.T., Ratcliffe, J., Street, D.: An Australian discrete choice experiment to value EQ-5D health states. Health Econ. 23(6), 729–742 (2014)CrossRefPubMed
23.
go back to reference Ratcliffe, J., Flynn, T., Terlich, F., Stevens, K., Brazier, J., Sawyer, M.: Developing adolescent-specific health state values for economic evaluation: An application of profile case best-worst scaling to the Child Health Utility 9D. Pharmacoeconomics. 30, 713–727 (2012)CrossRefPubMed Ratcliffe, J., Flynn, T., Terlich, F., Stevens, K., Brazier, J., Sawyer, M.: Developing adolescent-specific health state values for economic evaluation: An application of profile case best-worst scaling to the Child Health Utility 9D. Pharmacoeconomics. 30, 713–727 (2012)CrossRefPubMed
24.
go back to reference Mulhern, B.J., Bansback, N., Norman, R., Brazier, J., Group, S.-D.I.P.: Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Med. Care. 58(6), 566–573 (2020)CrossRefPubMed Mulhern, B.J., Bansback, N., Norman, R., Brazier, J., Group, S.-D.I.P.: Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Med. Care. 58(6), 566–573 (2020)CrossRefPubMed
25.
go back to reference Mulhern, B., Norman, R., Brazier, J., Valuing: SF-6Dv2 in Australia using an international protocol. PharmacoEconomics. 39, 1151–1162 (2021)CrossRefPubMed Mulhern, B., Norman, R., Brazier, J., Valuing: SF-6Dv2 in Australia using an international protocol. PharmacoEconomics. 39, 1151–1162 (2021)CrossRefPubMed
26.
go back to reference Norman, R., Mulhern, B., Lancsar, E., Lorgelly, P., Ratcliffe, J., Street, D., Viney, R.: The Use of a Discrete Choice Experiment Including both Duration and Dead for the development of an EQ-5D-5L value set for Australia. PharmacoEconomics. 41(4), 427–438 (2023)CrossRefPubMedPubMedCentral Norman, R., Mulhern, B., Lancsar, E., Lorgelly, P., Ratcliffe, J., Street, D., Viney, R.: The Use of a Discrete Choice Experiment Including both Duration and Dead for the development of an EQ-5D-5L value set for Australia. PharmacoEconomics. 41(4), 427–438 (2023)CrossRefPubMedPubMedCentral
27.
go back to reference Krucien, N., Watson, V., Ryan, M.: Is best–worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 26(12), e1–e16 (2017)CrossRefPubMed Krucien, N., Watson, V., Ryan, M.: Is best–worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 26(12), e1–e16 (2017)CrossRefPubMed
28.
go back to reference Xie, F., Pullenayegum, E., Gaebel, K., Oppe, M., Krabbe, P.F.: Eliciting preferences to the EQ-5D-5L health states: Discrete choice experiment or multiprofile case of best–worst scaling? Eur. J. Health Econ. 15, 281–288 (2014)CrossRefPubMed Xie, F., Pullenayegum, E., Gaebel, K., Oppe, M., Krabbe, P.F.: Eliciting preferences to the EQ-5D-5L health states: Discrete choice experiment or multiprofile case of best–worst scaling? Eur. J. Health Econ. 15, 281–288 (2014)CrossRefPubMed
29.
go back to reference Poder, T.G., Carrier, N., Kouakou, C.R.: Quebec health-related quality-of-life population norms using the EQ-5D-5L: Decomposition by sociodemographic data and health problems. Value Health. 23(2), 251–259 (2020)CrossRefPubMed Poder, T.G., Carrier, N., Kouakou, C.R.: Quebec health-related quality-of-life population norms using the EQ-5D-5L: Decomposition by sociodemographic data and health problems. Value Health. 23(2), 251–259 (2020)CrossRefPubMed
30.
go back to reference Poder, T.G., Ameri, H.: A Novel Approach for Health State Valuation: Multiple bounded dichotomous choice compared to the Traditional Standard Gamble. Soc. Sci. Med. 117173. (2024) Poder, T.G., Ameri, H.: A Novel Approach for Health State Valuation: Multiple bounded dichotomous choice compared to the Traditional Standard Gamble. Soc. Sci. Med. 117173. (2024)
31.
go back to reference Daroudi, R., Zeraati, H., Poder, T.G., Norman, R., Olyaeemanesh, A., Sari, A.A., Ameri, H.: Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Qual. Life Res. 33(7), 1853–1863 (2024)CrossRefPubMed Daroudi, R., Zeraati, H., Poder, T.G., Norman, R., Olyaeemanesh, A., Sari, A.A., Ameri, H.: Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Qual. Life Res. 33(7), 1853–1863 (2024)CrossRefPubMed
32.
go back to reference Ameri, H., Poder, T.G., Valuing: SF 6Dv2 using a Discrete Choice Experiment in a General Population in Quebec, Canada. Int. J. Health Policy Manage. (2024) Ameri, H., Poder, T.G., Valuing: SF 6Dv2 using a Discrete Choice Experiment in a General Population in Quebec, Canada. Int. J. Health Policy Manage. (2024)
33.
go back to reference Ferreira, L.N., Ferreira, P.L., Pereira, L.N., Brazier, J., Rowen, D.: A Portuguese value set for the SF-6D. Value Health. 13(5), 624–630 (2010)CrossRefPubMed Ferreira, L.N., Ferreira, P.L., Pereira, L.N., Brazier, J., Rowen, D.: A Portuguese value set for the SF-6D. Value Health. 13(5), 624–630 (2010)CrossRefPubMed
34.
go back to reference Al Shabasy, S., Abbassi, M., Finch, A., Roudijk, B., Baines, D., Farid, S.: The EQ-5D-5L valuation study in Egypt. Pharmacoeconomics. 40(4), 433–447 (2022)CrossRefPubMed Al Shabasy, S., Abbassi, M., Finch, A., Roudijk, B., Baines, D., Farid, S.: The EQ-5D-5L valuation study in Egypt. Pharmacoeconomics. 40(4), 433–447 (2022)CrossRefPubMed
35.
go back to reference Afshari, S., Daroudi, R., Goudarzi, R., Mahboub–Ahari, A., Yaseri, M., Sari, A.A., Ameri, H., Bahariniya, S., et al.: A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Qual. Life Res. 1–9. (2023) Afshari, S., Daroudi, R., Goudarzi, R., Mahboub–Ahari, A., Yaseri, M., Sari, A.A., Ameri, H., Bahariniya, S., et al.: A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Qual. Life Res. 1–9. (2023)
36.
go back to reference Swait, J., Louviere, J.: The role of the scale parameter in the estimation and comparison of multinomial logit models. J. Mark. Res. 30(3), 305–314 (1993)CrossRef Swait, J., Louviere, J.: The role of the scale parameter in the estimation and comparison of multinomial logit models. J. Mark. Res. 30(3), 305–314 (1993)CrossRef
37.
go back to reference Reyna, V.F., Nelson, W.L., Han, P.K., Dieckmann, N.F.: How numeracy influences risk comprehension and medical decision making. Psychol. Bull. 135(6), 943 (2009)CrossRefPubMedPubMedCentral Reyna, V.F., Nelson, W.L., Han, P.K., Dieckmann, N.F.: How numeracy influences risk comprehension and medical decision making. Psychol. Bull. 135(6), 943 (2009)CrossRefPubMedPubMedCentral
38.
go back to reference Cokely, E.T., Galesic, M., Schulz, E., Ghazal, S., Garcia-Retamero, R.: Measuring risk literacy: The Berlin numeracy test. Judgm. Decis. Mak. 7(1), 25–47 (2012)CrossRef Cokely, E.T., Galesic, M., Schulz, E., Ghazal, S., Garcia-Retamero, R.: Measuring risk literacy: The Berlin numeracy test. Judgm. Decis. Mak. 7(1), 25–47 (2012)CrossRef
39.
go back to reference Xie, S., Wu, J., He, X., Chen, G., Brazier, J.E.: Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in China. Value Health. 23(10), 1391–1399 (2020)CrossRefPubMed Xie, S., Wu, J., He, X., Chen, G., Brazier, J.E.: Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in China. Value Health. 23(10), 1391–1399 (2020)CrossRefPubMed
40.
go back to reference Shiroiwa, T., Ikeda, S., Noto, S., Igarashi, A., Fukuda, T., Saito, S., Shimozuma, K.: Comparison of value set based on DCE and/or TTO data: Scoring for EQ-5D-5L health states in Japan. Value Health. 19(5), 648–654 (2016)CrossRefPubMed Shiroiwa, T., Ikeda, S., Noto, S., Igarashi, A., Fukuda, T., Saito, S., Shimozuma, K.: Comparison of value set based on DCE and/or TTO data: Scoring for EQ-5D-5L health states in Japan. Value Health. 19(5), 648–654 (2016)CrossRefPubMed
41.
go back to reference Brazier, J.E., Roberts, J.: The estimation of a preference-based measure of health from the SF-12. Med. Care 851–859. (2004) Brazier, J.E., Roberts, J.: The estimation of a preference-based measure of health from the SF-12. Med. Care 851–859. (2004)
42.
go back to reference Kouakou, C.R., He, J., Poder, T.G.: Estimating the monetary value of a quality-adjusted life-year in Quebec. Eur. J. Health Econ. 1–25. (2023) Kouakou, C.R., He, J., Poder, T.G.: Estimating the monetary value of a quality-adjusted life-year in Quebec. Eur. J. Health Econ. 1–25. (2023)
43.
go back to reference Bansback, N., Hole, A.R., Mulhern, B., Tsuchiya, A.: Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues. Soc. Sci. Med. 114, 38–48 (2014)CrossRefPubMedPubMedCentral Bansback, N., Hole, A.R., Mulhern, B., Tsuchiya, A.: Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues. Soc. Sci. Med. 114, 38–48 (2014)CrossRefPubMedPubMedCentral
44.
go back to reference Lacey, H.P., Fagerlin, A., Loewenstein, G., Smith, D.M., Riis, J., Ubel, P.A.: It must be awful for them: Perspective and task context affects ratings for health conditions. Judgm. Decis. Mak. 1(2), 146–152 (2006)CrossRef Lacey, H.P., Fagerlin, A., Loewenstein, G., Smith, D.M., Riis, J., Ubel, P.A.: It must be awful for them: Perspective and task context affects ratings for health conditions. Judgm. Decis. Mak. 1(2), 146–152 (2006)CrossRef
45.
go back to reference Gyrd-Hansen, D., Halvorsen, P., Nexøe, J., Nielsen, J., Støvring, H., Kristiansen, I.: Joint and separate evaluation of risk reduction: Impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats. Med. Decis. Making. 31(1), E1–E10 (2011)CrossRefPubMed Gyrd-Hansen, D., Halvorsen, P., Nexøe, J., Nielsen, J., Støvring, H., Kristiansen, I.: Joint and separate evaluation of risk reduction: Impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats. Med. Decis. Making. 31(1), E1–E10 (2011)CrossRefPubMed
46.
go back to reference Brazier, J., Rowen, D., Yang, Y., Tsuchiya, A.: Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. Eur. J. Health Econ. 13, 575–587 (2012)CrossRefPubMed Brazier, J., Rowen, D., Yang, Y., Tsuchiya, A.: Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. Eur. J. Health Econ. 13, 575–587 (2012)CrossRefPubMed
47.
go back to reference Wu, J., Xie, S., He, X., Chen, G., Bai, G., Feng, D., Hu, M., Jiang, J., et al.: Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. Pharmacoeconomics. 39, 521–535 (2021)CrossRefPubMedPubMedCentral Wu, J., Xie, S., He, X., Chen, G., Bai, G., Feng, D., Hu, M., Jiang, J., et al.: Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. Pharmacoeconomics. 39, 521–535 (2021)CrossRefPubMedPubMedCentral
48.
go back to reference Wang, L., Poder, T.G.: A systematic review of SF-6D health state valuation studies. J. Med. Econ. 26(1), 584–593 (2023)CrossRefPubMed Wang, L., Poder, T.G.: A systematic review of SF-6D health state valuation studies. J. Med. Econ. 26(1), 584–593 (2023)CrossRefPubMed
49.
go back to reference Bleichrodt, H., Johannesson, M.: Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. J. Health. Econ. 16(2), 155–175 (1997)CrossRefPubMed Bleichrodt, H., Johannesson, M.: Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. J. Health. Econ. 16(2), 155–175 (1997)CrossRefPubMed
Metadata
Title
Comparison of four approaches in eliciting health state utilities with SF-6Dv2
Authors
Hosein Ameri
Thomas G. Poder
Publication date
28-09-2024
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-024-01723-w